ISO code and name
of the third country or territory
Code of the zone
as set out in Part 2
Categoriesof germinal products
permitted to enter the Union
Animal health certificates |
Specific conditions
as set out in Part 3
Animal health guarantees
as set out in Part 4
1 | 2 | 3 | 4 | 5 | 6
AR
Argentina
AR-0 | Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
AU
Australia
AU-0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
EHD-test
BTV-test
Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
EHD-test
BTV-test
CA
Canada
CA-0 | Semen | Commission Decision 2005/290/EC | |
SF-BTV
SF-EHD
EHD-test
BTV-test
Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
SF-BTV
SF-EHD
EHD-test
BTV-test
CH
Switzerland
CH - 0 | Semen | Subject to the Agreement referred to in point 7 of Annex I |
Oocytes and embryos
CL
Chile
CL - 0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
GB
United Kingdom
GB-1 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021 |
BRU
EBL
BTV-test
Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021
GB-2 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021 |
BRU
TB
EBL
BTV-test
Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021
GG
Guernsey
GG-0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021 |
Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021 |
GL
Greenland
GL - 0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
IL
Israel
IL-0 | Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
IS
Iceland
IS-0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
IM
Isle of Man
IM-0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021 |
BRU
TB
EBL
Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021
JE
Jersey
JE-0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021 | EBL
Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
Period before 1 January 2021
MK
North Macedonia
MK-0 | Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
BTV-test
NZ
New Zealand
NZ-0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
TB, BRU, BTV
Oocytes and embryos |
Annex I to Commission Implementing Decision (EU) 2015/1901
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
TB, BRU, BTV
PM
Saint Pierre et Miquelon
PM-0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
US
United States
US-0 | Semen |
BOV-SEM-A-ENTRY
BOV-SEM-B-ENTRY
BOV-SEM-C-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
EHD-test
BTV-test
Oocytes and embryos |
BOV-OOCYTES-EMB-A-ENTRY
BOV-in-vivo-EMB-B-ENTRY
BOV-in-vitro-EMB-C-ENTRY
BOV-in-vitro-EMB-D-ENTRY
BOV-GP-PROCESSING-ENTRY
BOV-GP-STORAGE-ENTRY
EHD-test
BTV-test
Name of the third country or territory | Code of the zone | Description of the zone
United Kingdom | GB-1 | England and Wales
GB-2 | Scotland
[Commission Implementing Regulation (EU) 2021/403 of 24 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU (OJ L 113, 31.3.2021, p. 1).]
Period before 1 January 2021 | The model certificates to be used for entry into the Union of semen, oocytes and embryos from the zone referred to in column 2 of the table set out in Part 1 collected or produced, processed and stored before 1 January 2021 are set out in Chapters 24, 25, 27, 28 and 29 of Annex I to Commission Implementing Regulation (EU) 2021/403
EHD-test | Compulsory testing for infection with epizootic haemorrhagic disease virus – consignments of semen, in vitro produced embryos and oocytes
BTV-test | Compulsory testing for infection with bluetongue virus– consignments of semen, in vitro produced embryos and oocytes
BRU | The Union has recognised freedom from infection with Brucellaabortus, B. melitensis and B. suis of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692
TB | The Union has recognised freedom from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692
BTV | The Union has recognised freedom from infection with bluetongue virus (serotypes 1-24) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692
SF-BTV | The Union has recognised seasonal freedom from infection with bluetongue virus (serotypes 1-24) of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Implementing Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692
SF-EHD | The Union has recognised seasonal freedom from infection with epizootic haemorrhagic disease virus of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692
EBL | The Union has recognised freedom from enzootic bovine leukosis of the third country, territory or zone as regards the specific species of animals referred to in column 3 of the table set out in Part 1 of Annex II to this Regulation, in accordance with Article 10 of Delegated Regulation (EU) 2020/692